IGC Pharma Inc. (IGC)
NYSE · Healthcare
IGC Pharma Inc. Revenue 2011–2025
IGC Pharma Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IGC Pharma Inc. revenue for the quarter ending March 31, 2026 was 317000, a 3.94% decrease year-over-year.
- IGC Pharma Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M, a 1.83% increase year-over-year.
- IGC Pharma Inc. annual revenue for 2025 was 1.3 M, a 5.50% decrease from 2024.
- IGC Pharma Inc. annual revenue for 2024 was 1.3 M, a 47.64% increase from 2023.
- IGC Pharma Inc. annual revenue for 2023 was 911000, a 129.47% increase from 2022.
- IGC Pharma Inc. annual revenue for 2022 was 397000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
IGC Pharma Inc. Revenue — FAQ
IGC Pharma Inc. (IGC) revenue over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is IGC Pharma Inc.'s revenue?
IGC Pharma Inc. (IGC) reported revenue of $1M for fiscal 2025.
Where can I see IGC's revenue history?
The chart and table above show IGC Pharma Inc.'s revenue by year and by quarter, including the growth rate.